跳至主要内容
临床试验/NCT05160064
NCT05160064撤回不适用

Long-term Longitudinal Cohort Registry of Patients Treated With Loncastuximab Tesirine

ADC Therapeutics S.A.1 个研究点 分布在 1 个国家开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Number of Patients with Adverse Events

研究概览

简要总结

Retrospective and prospective multi-center observational study of patients with B-cell lymphomas treated with loncastuximab tesirine treatment in real-world practice.

详细描述

The purpose of this study is to assess treatment patterns and generate evidence on the effectiveness and safety of loncastuximab tesirine treatment in real-world practice. This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(j)(4)(A) of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be ≥ 18 years of age at the time of consent.
  • Initiated or initiating commercially available loncastuximab tesirine treatment.
  • Written informed consent must be obtained prior to any registry activities.

排除标准

  • Prior loncastuximab tesirine exposure in clinical trials.

结局指标

主要结局

Number of Patients with Adverse Events

时间窗: Up to 48 Months

Includes serious adverse events (SAEs) and adverse events (AEs) Grade 3 or higher for the events of: edema, myelosuppression, infections, and cutaneous reactions.

Time to Partial Response (PR)

时间窗: Up to 48 Months

Time to Complete Response (CR)

时间窗: Up to 48 Months

Progression-free Survival (PFS)

时间窗: Up to 48 Months

Overall Survival (OS)

时间窗: Up to 48 Months

Overall Response Rate (ORR)

时间窗: Up to 48 Months

Duration of Response (DoR)

时间窗: Up to 48 Months

Time to Disease Progression

时间窗: Up to 48 Months

次要结局

  • Number of Hospitalizations(Up to 48 Months)
  • Reasons for Surgeries(Up to 48 Months)
  • Reasons for Outpatient Visits(Up to 48 Months)
  • Number of Surgeries(Up to 48 Months)
  • Reasons for Emergency Room Visits(Up to 48 Months)
  • Number of Outpatient Visits(Up to 48 Months)
  • Duration of Hospitalizations(Up to 48 Months)
  • Number of Emergency Room Visits(Up to 48 Months)
  • Reasons for Hospitalizations(Up to 48 Months)
  • Type of Surgeries(Up to 48 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Long-term Registry of Patients Treated With... | 临床试验